SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-23-005249
Filing Date
2023-08-09
Accepted
2023-08-09 16:05:25
Documents
12
Period of Report
2023-08-07
Items
Item 2.01: Completion of Acquisition or Disposition of Assets

Document Format Files

Seq Description Document Type Size
1 8-K organicellregen_8k.htm   iXBRL 8-K 23232
  Complete submission text file 0001829126-23-005249.txt   190303

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE ocel-20230807.xsd EX-101.SCH 3021
3 XBRL LABEL FILE ocel-20230807_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE ocel-20230807_pre.xml EX-101.PRE 22363
6 EXTRACTED XBRL INSTANCE DOCUMENT organicellregen_8k_htm.xml XML 3044
Mailing Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314
Business Address 3321 COLLEGE AVENUE SUITE 246 DAVIE FL 33314 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 231155077
SIC: 2836 Biological Products, (No Diagnostic Substances)